Consolidated statements of income and comprehensive income/loss (-)

Consolidated financial statements
Consolidated income statement

 

Year ended 31 December

 

(thousands of €, except per share data)

2019

2018

Notes

Revenues

844,985

288,836

6

Other income

50,905

29,009

6

Total revenues and other income

895,890

317,845

 

 

 

 

 

Research and development expenditure

(427,320)

(322,875)

7

General and administrative expenses

(73,701)

(35,631)

7

Sales and marketing expenses

(24,577)

(4,146)

7

Total operating expenses

(525,597)

(362,652)

 

 

 

 

 

Operating profit/loss (-)

370,292

(44,807)

 

 

 

 

 

Fair value re-measurement of share subscription agreement and warrants

(181,644)

9

Other financial income

21,482

18,335

10

Other financial expenses

(60,071)

(2,737)

10

 

 

 

 

Profit/loss (-) before tax

150,060

(29,209)

 

 

 

 

 

Income taxes

(214)

(50)

11

 

 

 

 

Net profit/loss (-)

149,845

(29,259)

 

Net profit/loss (-) attributable to:

 

 

 

Owners of the parent

149,845

(29,259)

 

Basic income/loss (-) per share

2.60

(0.56)

12

Diluted income/loss (-) per share

2.49

(0.56)

12

The accompanying notes form an integral part of these financial statements.

Consolidated statement of comprehensive income / loss (-)

 

Year ended 31 December

 

(thousands of €)

2019

2018

Notes

Net profit/loss (-)

149,845

(29,259)

 

Items that will not be reclassified subsequently to profit or loss:

 

 

 

Re-measurement of defined benefit obligation

(4,107)

(94)

 

Items that may be reclassified subsequently to profit or loss:

 

 

 

Translation differences, arisen from translating foreign activities

415

197

 

Other comprehensive income/loss (-), net of income tax

(3,692)

103

 

 

 

 

 

Total comprehensive income/loss (-) attributable to:

 

 

 

Owners of the parent

146,154

(29,155)

 

The accompanying notes form an integral part of these financial statements.